0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-12-01 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 05998535 2024-12-01 2025-11-30 05998535 2025-11-30 05998535 2024-11-30 05998535 2023-12-01 2024-11-30 05998535 2024-11-30 05998535 2023-11-30 05998535 bus:OrdinaryShareClass1 2024-12-01 2025-11-30 05998535 bus:OrdinaryShareClass2 2024-12-01 2025-11-30 05998535 bus:Director1 2024-12-01 2025-11-30 05998535 core:WithinOneYear 2025-11-30 05998535 core:WithinOneYear 2024-11-30 05998535 core:ShareCapital 2025-11-30 05998535 core:ShareCapital 2024-11-30 05998535 core:RetainedEarningsAccumulatedLosses 2025-11-30 05998535 core:RetainedEarningsAccumulatedLosses 2024-11-30 05998535 bus:SmallEntities 2024-12-01 2025-11-30 05998535 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 05998535 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 05998535 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 05998535 bus:FullAccounts 2024-12-01 2025-11-30 05998535 bus:OrdinaryShareClass1 2025-11-30 05998535 bus:OrdinaryShareClass1 2024-11-30 05998535 bus:OrdinaryShareClass2 2025-11-30 05998535 bus:OrdinaryShareClass2 2024-11-30 05998535 bus:AllOrdinaryShares 2025-11-30 05998535 bus:AllOrdinaryShares 2024-11-30
COMPANY REGISTRATION NUMBER: 05998535
Denmylne Limited
Filleted Unaudited Financial Statements
30 November 2025
Denmylne Limited
Statement of Financial Position
30 November 2025
2025
2024
Note
£
£
£
Current assets
Stocks
621,431
613,879
Debtors
4
8,572
8,572
Cash at bank and in hand
1
1
--------
--------
630,004
622,452
Creditors: amounts falling due within one year
5
320,484
312,932
--------
--------
Net current assets
309,520
309,520
--------
--------
Total assets less current liabilities
309,520
309,520
--------
--------
Capital and reserves
Called up share capital
6
283,351
283,351
Profit and loss account
26,169
26,169
--------
--------
Shareholders funds
309,520
309,520
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 27 August 2026 , and are signed on behalf of the board by:
J.A. O'Meara
Director
Company registration number: 05998535
Denmylne Limited
Notes to the Financial Statements
Year ended 30 November 2025
1. General information
The company is a private company limited by shares, incorporated, registered and trading in England and Wales with company number 05998535 . The address of the registered office is 3 Trinity Street, Leamington Spa, Warwickshire, CV32 5YN.
2. Statement of compliance
The financial statements have been prepared in accordance with applicable United Kingdom accounting standards, including Financial Reporting Standard 102 Section 1A smaller entities 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' ('FRS 102') and Companies Act 2006.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss. The financial statements are prepared in sterling, which is the functional currency of the company and rounded to the nearest £.
Judgements in applying accounting policies and key sources of estimation in uncertainty
In preparing these financial statements the director has had to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historic experience and various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates. For this reporting date there are no significant judgements, estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amounts of the assets and liabilities.
Stocks
Development stock is valued on the basis of direct costs plus attributable overheads and interest accrued on related loans based on normal level of activity. Provision is made for any foreseeable losses where appropriate. No element of profit is included in the valuation.
4. Debtors
2025
2024
£
£
Other debtors
8,572
8,572
------
------
5. Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
320,484
312,932
--------
--------
6. Called up share capital
Issued, called up and fully paid
2025
2024
No.
£
No.
£
Ordinary shares of £ 1 each
1
1
1
1
Preference shares of £ 1 each
283,350
283,350
283,350
283,350
--------
--------
--------
--------
283,351
283,351
283,351
283,351
--------
--------
--------
--------
7. Director's advances, credits and guarantees
At the reporting date the directors loan account was in credit by £111,438 (2024: £104,838). There is no fixed term for repayment and no interest is charged.
8. Related party transactions
The company was under the control of Mr J. O'Meara throughout the current and previous year.